<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Kawashiri, Masa-aki</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">MILLION Study</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-06-25 12:08:30</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">7-8</style></pages><abstract><style  face="normal" font="default" size="100%">The MILLION study shows that aggressive, simultaneous treatment with an amlodipine- and statin-based regimen lowers blood pressure and low-density lipoprotein cholesterol to a greater extent than standard intensity treatment in a Japanese population. However, percent change in coronary plaque volume, and lumen and vessel volume were similar among both treatment arms.</style></abstract><number><style face="normal" font="default" size="100%">10</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>